{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:19:20Z","timestamp":1776928760936,"version":"3.51.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17pc0101007"],"award-info":[{"award-number":["JP17pc0101007"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in activin receptor-like kinase 2 (ALK2) can cause the pathological osteogenic signaling seen in some patients with fibrodysplasia ossificans progressiva and other conditions such as diffuse intrinsic pontine glioma. Here, we report that intracellular domain of wild-type ALK2 readily dimerizes in response to BMP7 binding to drive osteogenic signaling. This osteogenic signaling is pathologically triggered by heterotetramers of type II receptor kinases and ALK2 mutant forms, which form intracellular domain dimers in response to activin A binding. We develop a blocking monoclonal antibody, Rm0443, that can suppress ALK2 signaling. We solve the crystal structure of the ALK2 extracellular domain complex with a Fab fragment of Rm0443 and show that Rm0443 induces dimerization of ALK2 extracellular domains in a back-to-back orientation on the cell membrane by binding the residues H64 and F63 on opposite faces of the ligand-binding site. Rm0443 could prevent heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva that carries the human R206H pathogenic mutant.<\/jats:p>","DOI":"10.1038\/s41467-023-38746-5","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T10:02:39Z","timestamp":1685008959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-2098","authenticated-orcid":false,"given":"Takenobu","family":"Katagiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-6651","authenticated-orcid":false,"given":"Sho","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5605-9197","authenticated-orcid":false,"given":"Mai","family":"Kuratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4848-1942","authenticated-orcid":false,"given":"Kensuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ohte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0171-6476","authenticated-orcid":false,"given":"Yoshiro","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2657-9738","authenticated-orcid":false,"given":"Kiyosumi","family":"Takaishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"38746_CR1","doi-asserted-by":"crossref","first-page":"a021899","DOI":"10.1101\/cshperspect.a021899","volume":"8","author":"T Katagiri","year":"2016","unstructured":"Katagiri, T. & Watabe, T. Bone morphogenetic proteins. Cold Spring Harb. Perspect. Biol. 8, a021899 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"38746_CR2","doi-asserted-by":"crossref","first-page":"115549","DOI":"10.1016\/j.bone.2020.115549","volume":"140","author":"GR Gipson","year":"2020","unstructured":"Gipson, G. R. et al. Structural perspective of BMP ligands and signaling. Bone 140, 115549 (2020).","journal-title":"Bone"},{"key":"38746_CR3","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.febslet.2012.02.043","volume":"586","author":"TD Mueller","year":"2012","unstructured":"Mueller, T. D. & Nickel, J. Promiscuity and specificity in BMP receptor activation. FEBS Lett. 586, 1846\u20131859 (2012).","journal-title":"FEBS Lett."},{"key":"38746_CR4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrendo.2016.12","volume":"12","author":"VS Salazar","year":"2016","unstructured":"Salazar, V. S., Gamer, L. W. & Rosen, V. BMP signalling in skeletal development, disease and repair. Nat. Rev. Endocrinol. 12, 203\u2013221 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"38746_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bone.2017.07.024","volume":"109","author":"T Katagiri","year":"2018","unstructured":"Katagiri, T., Tsukamoto, S. & Kuratani, M. Heterotopic bone induction via BMP signaling: potential therapeutic targets for fibrodysplasia ossificans progressiva. Bone 109, 241\u2013250 (2018).","journal-title":"Bone"},{"key":"38746_CR6","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/j.1460-2075.1995.tb07214.x","volume":"14","author":"R Wieser","year":"1995","unstructured":"Wieser, R., Wrana, J. L. & Massagu\u00e9, J. GS domain mutations that constitutively activate T\u03b2R-I, the downstream signaling component in the TGF-\u03b2 receptor complex. EMBO J. 14, 2199\u20132208 (1995).","journal-title":"EMBO J."},{"key":"38746_CR7","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.273.40.25628","volume":"273","author":"M Macias-Silva","year":"1998","unstructured":"Macias-Silva, M., Hoodless, P. A., Tang, S. J., Buchwald, M. & Wrana, J. L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273, 25628\u201325636 (1998).","journal-title":"J. Biol. Chem."},{"key":"38746_CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/me.2014-1301","volume":"29","author":"M Fujimoto","year":"2015","unstructured":"Fujimoto, M. et al. Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors. Mol. Endocrinol. 29, 140\u2013152 (2015).","journal-title":"Mol. Endocrinol."},{"key":"38746_CR9","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1128\/MCB.01595-12","volume":"33","author":"J Bagarova","year":"2013","unstructured":"Bagarova, J. et al. Constitutively active ALK2 receptor mutants require type II receptor cooperation. Mol. Cell Biol. 33, 2413\u20132424 (2013).","journal-title":"Mol. Cell Biol."},{"key":"38746_CR10","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M102750200","volume":"277","author":"A Nohe","year":"2002","unstructured":"Nohe, A. et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277, 5330\u20135338 (2002).","journal-title":"J. Biol. Chem."},{"key":"38746_CR11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/biomedicines9070736","volume":"9","author":"T Katagiri","year":"2021","unstructured":"Katagiri, T., Tsukamoto, S. & Kuratani, M. Accumulated knowledge of activin receptor-like kinase 2 (ALK2)\/activin A receptor, type 1 (ACVR1) as a target for human disorders. Biomedicines 9, 736 (2021).","journal-title":"Biomedicines"},{"key":"38746_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1349-0079(10)80006-4","volume":"52","author":"T Katagiri","year":"2010","unstructured":"Katagiri, T. Heterotopic bone formation induced by bone morphogenetic protein signaling: fibrodysplasia ossificans progressiva. J. Oral Biosci. 52, 33\u201341 (2010).","journal-title":"J. Oral Biosci."},{"key":"38746_CR13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1242\/dmm.010280","volume":"5","author":"FS Kaplan","year":"2012","unstructured":"Kaplan, F. S., Chakkalakal, S. A. & Shore, E. M. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis. Model. Mech. 5, 756\u2013762 (2012).","journal-title":"Dis. Model. Mech."},{"key":"38746_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tibs.2015.11.010","volume":"41","author":"T Katagiri","year":"2016","unstructured":"Katagiri, T. A door opens for fibrodysplasia ossificans progressiva. Trends Biochem. Sci. 41, 119\u2013121 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"38746_CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore, E. M. et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525\u2013527 (2006).","journal-title":"Nat. Genet."},{"key":"38746_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajmg.a.32151","volume":"146A","author":"H Furuya","year":"2008","unstructured":"Furuya, H. et al. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am. J. Med. Genet. A 146A, 459\u2013463 (2008).","journal-title":"Am. J. Med. Genet. A"},{"key":"38746_CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ejhg.2008.178","volume":"17","author":"R Bocciardi","year":"2009","unstructured":"Bocciardi, R., Bordo, D., Di Duca, M., Di Rocco, M. & Ravazzolo, R. Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur. J. Hum. Genet. 17, 311\u2013318 (2009).","journal-title":"Eur. J. Hum. Genet."},{"key":"38746_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","volume":"30","author":"FS Kaplan","year":"2009","unstructured":"Kaplan, F. S. et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum. Mutat. 30, 379\u2013390 (2009).","journal-title":"Hum. Mutat."},{"key":"38746_CR19","doi-asserted-by":"crossref","first-page":"e5005","DOI":"10.1371\/journal.pone.0005005","volume":"4","author":"KA Petrie","year":"2009","unstructured":"Petrie, K. A. et al. Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. PLoS ONE 4, e5005 (2009).","journal-title":"PLoS ONE"},{"key":"38746_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10067-009-1283-z","volume":"29","author":"I Ratbi","year":"2010","unstructured":"Ratbi, I., Bocciardi, R., Regragui, A., Ravazzolo, R. & Sefiani, A. Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. Clin. Rheumatol. 29, 119\u2013121 (2010).","journal-title":"Clin. Rheumatol."},{"key":"38746_CR21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bone.2010.10.164","volume":"48","author":"CL Gregson","year":"2011","unstructured":"Gregson, C. L. et al. A novel ACVR1 mutation in the glycine\/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date. Bone 48, 654\u2013658 (2011).","journal-title":"Bone"},{"key":"38746_CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jbmr.1473","volume":"27","author":"MP Whyte","year":"2012","unstructured":"Whyte, M. P. et al. Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1. J. Bone Miner. Res. 27, 729\u2013737 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"38746_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajmg.a.36219","volume":"164A","author":"Y Nakahara","year":"2014","unstructured":"Nakahara, Y., Katagiri, T., Ogata, N. & Haga, N. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report. Am. J. Med. Genet. A 164A, 220\u2013224 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"38746_CR24","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/ajmg.a.37205","volume":"167A","author":"FS Kaplan","year":"2015","unstructured":"Kaplan, F. S. et al. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): a report of two patients. Am. J. Med. Genet. A 167A, 2265\u20132271 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"38746_CR25","doi-asserted-by":"crossref","first-page":"15055","DOI":"10.1038\/hgv.2015.55","volume":"2","author":"Y Nakahara","year":"2015","unstructured":"Nakahara, Y., Suzuki, R., Katagiri, T., Toguchida, J. & Haga, N. Phenotypic differences of patients with fibrodysplasia ossificans progressive due to p.Arg258Ser variants of ACVR1. Hum. Genome Var. 2, 15055 (2015).","journal-title":"Hum. Genome Var."},{"key":"38746_CR26","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","volume":"287","author":"A Chaikuad","year":"2012","unstructured":"Chaikuad, A. et al. Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva. J. Biol. Chem. 287, 36990\u201336998 (2012).","journal-title":"J. Biol. Chem."},{"key":"38746_CR27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz, P. et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat. Genet. 46, 451\u2013456 (2014).","journal-title":"Nat. Genet."},{"key":"38746_CR28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso, A. M. et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat. Genet. 46, 462\u2013466 (2014).","journal-title":"Nat. Genet."},{"key":"38746_CR29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor, K. R. et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat. Genet. 46, 457\u2013461 (2014).","journal-title":"Nat. Genet."},{"key":"38746_CR30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444\u2013450 (2014).","journal-title":"Nat. Genet."},{"key":"38746_CR31","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ajmg.a.61274","volume":"179","author":"A Gupta","year":"2019","unstructured":"Gupta, A. et al. Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification. Am. J. Med. Genet. A 179, 1764\u20131777 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"38746_CR32","doi-asserted-by":"crossref","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","volume":"7","author":"SJ Hatsell","year":"2015","unstructured":"Hatsell, S. J. et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci. Transl. Med. 7, 303ra137 (2015).","journal-title":"Sci. Transl. Med."},{"key":"38746_CR33","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","volume":"112","author":"K Hino","year":"2015","unstructured":"Hino, K. et al. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Proc. Natl Acad. Sci. USA 112, 15438\u201315443 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"38746_CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2018.03.015","volume":"111","author":"A Machiya","year":"2018","unstructured":"Machiya, A. et al. Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders. Bone 111, 101\u2013108 (2018).","journal-title":"Bone"},{"key":"38746_CR35","doi-asserted-by":"crossref","first-page":"115410","DOI":"10.1016\/j.bone.2020.115410","volume":"137","author":"S Tsukamoto","year":"2020","unstructured":"Tsukamoto, S., Kuratani, M. & Katagiri, T. Functional characterization of a unique mutant of ALK2, p.K400E, that is associated with a skeletal disorder, diffuse idiopathic skeletal hyperostosis. Bone 137, 115410 (2020).","journal-title":"Bone"},{"key":"38746_CR36","doi-asserted-by":"crossref","first-page":"e54582","DOI":"10.7554\/eLife.54582","volume":"9","author":"S Aykul","year":"2020","unstructured":"Aykul, S. et al. Activin A forms a non-signaling complex with ACVR1 and type II Activin\/BMP receptors via its finger 2 tip loop. eLife 9, e54582 (2020).","journal-title":"eLife"},{"key":"38746_CR37","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6807-7-6","volume":"7","author":"D Weber","year":"2007","unstructured":"Weber, D. et al. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor. BMC Struct. Biol. 7, 6 (2007).","journal-title":"BMC Struct. Biol."},{"key":"38746_CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1107\/S205225251402209X","volume":"2","author":"X Tian","year":"2015","unstructured":"Tian, X. et al. In-depth analysis of subclass-specific conformational preferences of IgG antibodies. IUCrJ 2, 9\u201318 (2015).","journal-title":"IUCrJ"},{"key":"38746_CR39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","volume":"11","author":"AS Dixon","year":"2016","unstructured":"Dixon, A. S. et al. NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem. Biol. 11, 400\u2013408 (2016).","journal-title":"ACS Chem. Biol"},{"key":"38746_CR40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acschembio.7b00549","volume":"13","author":"MK Schwinn","year":"2018","unstructured":"Schwinn, M. K. et al. CRISPR-mediated tagging of endogenous proteins with a luminescent peptide. ACS Chem. Biol. 13, 467\u2013474 (2018).","journal-title":"ACS Chem. Biol."},{"key":"38746_CR41","doi-asserted-by":"crossref","first-page":"e62721","DOI":"10.1371\/journal.pone.0062721","volume":"8","author":"CE Sanvitale","year":"2013","unstructured":"Sanvitale, C. E. et al. A new class of small molecule inhibitor of BMP signaling. PLoS ONE 8, e62721 (2013).","journal-title":"PLoS ONE"},{"key":"38746_CR42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80555-3","volume":"96","author":"M Huse","year":"1999","unstructured":"Huse, M., Chen, Y. G., Massagu\u00e9, J. & Kuriyan, J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell 96, 425\u2013436 (1999).","journal-title":"Cell"},{"key":"38746_CR43","doi-asserted-by":"crossref","first-page":"e153792","DOI":"10.1172\/JCI153792","volume":"132","author":"S Aykul","year":"2022","unstructured":"Aykul, S. et al. Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. J. Clin. Investig. 132, e153792 (2022).","journal-title":"J. Clin. Investig."},{"key":"38746_CR44","doi-asserted-by":"crossref","first-page":"e153795","DOI":"10.1172\/JCI153795","volume":"132","author":"JB Lees-Shepard","year":"2022","unstructured":"Lees-Shepard, J. B. et al. An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice. J. Clin. Investig. 132, e153795 (2022).","journal-title":"J. Clin. Investig."},{"key":"38746_CR45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1097-2765(03)00094-7","volume":"11","author":"J Greenwald","year":"2003","unstructured":"Greenwald, J. et al. The BMP7\/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605\u2013617 (2003).","journal-title":"Mol. Cell"},{"key":"38746_CR46","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cellsig.2011.04.004","volume":"23","author":"M Ehrlich","year":"2011","unstructured":"Ehrlich, M., Horbelt, D., Marom, B., Knaus, P. & Henis, Y. I. Homomeric and heteromeric complexes among TGF-beta and BMP receptors and their roles in signaling. Cell. Signal. 23, 1424\u20131432 (2011).","journal-title":"Cell. Signal."},{"key":"38746_CR47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25248-5","volume":"12","author":"C Agnew","year":"2021","unstructured":"Agnew, C. et al. Structural basis for ALK2\/BMPR2 receptor complex signaling through kinase domain oligomerization. Nat. Commun. 12, 4950 (2021).","journal-title":"Nat. Commun."},{"key":"38746_CR48","first-page":"3462","volume":"119","author":"Q Shen","year":"2009","unstructured":"Shen, Q. et al. The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J. Clin. Investig. 119, 3462\u20133472 (2009).","journal-title":"J. Clin. Investig."},{"key":"38746_CR49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000324230","volume":"194","author":"JC Groppe","year":"2011","unstructured":"Groppe, J. C., Wu, J., Shore, E. M. & Kaplan, F. S. In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells Tissues Organs 194, 291\u2013295 (2011).","journal-title":"Cells Tissues Organs"},{"key":"38746_CR50","volume":"9","author":"JB Lees-Shepard","year":"2018","unstructured":"Lees-Shepard, J. B. et al. Activin-dependent signaling in fibro\/adipogenic progenitors causes fibrodysplasia ossificans progressiva. Nat. Commun. 9, 471 (2018).","journal-title":"Nat. Commun."},{"key":"38746_CR51","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1083\/jcb.127.6.1755","volume":"127","author":"T Katagiri","year":"1994","unstructured":"Katagiri, T. et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755\u20131766 (1994).","journal-title":"J. Cell Biol."},{"key":"38746_CR52","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bbrc.2006.05.045","volume":"345","author":"K Kodaira","year":"2006","unstructured":"Kodaira, K. et al. Purification and identification of a BMP-like factor from bovine serum. Biochem. Biophys. Res. Commun. 345, 1224\u20131231 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"38746_CR53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2443.2002.00573.x","volume":"7","author":"T Katagiri","year":"2002","unstructured":"Katagiri, T. et al. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7, 949\u2013960 (2002).","journal-title":"Genes Cells"},{"key":"38746_CR54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbrc.2011.03.001","volume":"407","author":"S Ohte","year":"2011","unstructured":"Ohte, S. et al. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Biochem. Biophys. Res. Commun. 407, 213\u2013218 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"38746_CR55","volume":"4","author":"S Tsukamoto","year":"2014","unstructured":"Tsukamoto, S. et al. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Sci. Rep. 4, 7596 (2014).","journal-title":"Sci. Rep."},{"key":"38746_CR56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1107\/S0907444909047374","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D Biol. Crystallogr. 66, 133\u2013144 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"38746_CR57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"38746_CR58","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"38746_CR59","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1093\/bioinformatics\/btg362","volume":"19","author":"A Fiser","year":"2003","unstructured":"Fiser, A. & Sali, A. ModLoop: automated modeling of loops in protein structures. Bioinformatics 19, 2500\u20132501 (2003).","journal-title":"Bioinformatics"},{"key":"38746_CR60","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/prot.24551","volume":"82","author":"K Zhu","year":"2014","unstructured":"Zhu, K. et al. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction. Proteins 82, 1646\u20131655 (2014).","journal-title":"Proteins"},{"key":"38746_CR61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"38746_CR62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"38746_CR63","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nbt811","volume":"21","author":"F Schnutgen","year":"2003","unstructured":"Schnutgen, F. et al. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat. Biotechnol. 21, 562\u2013565 (2003).","journal-title":"Nat. Biotechnol."},{"key":"38746_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/dbio.2002.0597","volume":"244","author":"S Hayashi","year":"2002","unstructured":"Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation\/inactivation in the mouse. Dev. Biol. 244, 305\u2013318 (2002).","journal-title":"Dev. Biol."}],"updated-by":[{"DOI":"10.1038\/s41467-023-41873-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38746-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T19:04:12Z","timestamp":1700161452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38746-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38746"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-38746-5","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-023-41873-8","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-023-41873-8","URL":"https:\/\/doi.org\/10.1038\/s41467-023-41873-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.K. received research grants from Daiichi Sankyo, Co., Ltd. S. Tsukamoto, M.K., and S.O. declare no conflicts of interest in association with the present study. S. Tsuji, K.N., Y.K., and K.T. are employees of Daiichi Sankyo. Co., Ltd. T.K., S. Tsukamoto, M.K., S. Tsuji, K.N., and Y.K. are inventors in patents related to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2960"}}